Status:
TERMINATED
Evaluation of Ureteral Stents in the Management of Stone Disease
Lead Sponsor:
Washington University School of Medicine
Conditions:
Urinary Stones
Urinary Tract Stones
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
A thin tube, called a ureteral stent, is inserted into the ureter and is commonly used as treatment of urinary stone disease. Stents are designed to help provide drainage of the kidney in the setting ...
Eligibility Criteria
Inclusion
- Over 18 years of age and willing and able to provide informed consent
- Patients with current urinary stone disease, undergoing any of the following procedures:
- cystoscopy with stent placement
- ureteroscopy with intracorporeal lithotripsy
Exclusion
- Patients with compromised urinary tract due to cancer (e.g. bladder tumor, ureteral obstruction from non-GU malignancy)
- Patients requiring bilateral surgical stone management procedure
- Patients with any single stone exceeding 1.5 cm
- Patients with severe concurrent disease, infection, or co-morbidity that, in the judgment of the investigator, would render the patient inappropriate for enrollment
- Any patient who is on anticholinergic medication at baseline
Key Trial Info
Start Date :
August 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 3 2018
Estimated Enrollment :
41 Patients enrolled
Trial Details
Trial ID
NCT02211313
Start Date
August 1 2014
End Date
April 3 2018
Last Update
June 5 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington University School of Medicine
St Louis, Missouri, United States, 63110